In this issue:
Psilocybin for the treatment of cocaine use disorder
Adverse neurodevelopmental outcomes after prenatal exposure to buprenorphine or methadone
Risk of stimulant-related hospitalisations after initiation of psychostimulants or atomoxetine
Interventions for methamphetamine co-use among patients in methadone programmes
Effects of tirzepatide in a preclinical model of cocaine use disorder
Impact of varenicline medication samples on smoking cessation in adults
Efficacy of once-weekly semaglutide in adult smokers
Impact of cannabis edibles + alcohol on driving ability
Mirtazapine for methamphetamine use disorder
Implementing SBIRT for alcohol and other drugs in safety-sensitive industries in Australia
Patterns of e-cigarette use in Australia
Is methylphenidate a potential treatment for cocaine use disorder?
Please login below to download this issue (PDF)